These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
410 related items for PubMed ID: 11721174
21. Tumour markers in diagnosis and management. Warnes TW, Smith A. Baillieres Clin Gastroenterol; 1987 Jan; 1(1):63-89. PubMed ID: 2437983 [Abstract] [Full Text] [Related]
22. Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System. Tayob N, Richardson P, White DL, Yu X, Davila JA, Kanwal F, Feng Z, El-Serag HB. BMC Med Res Methodol; 2018 Jan 04; 18(1):1. PubMed ID: 29301497 [Abstract] [Full Text] [Related]
23. Fucosylated fraction of alpha-fetoprotein as a serological marker of early hepatocellular carcinoma. Moriya S, Morimoto M, Numata K, Nozaki A, Shimoyama Y, Kondo M, Nakano M, Maeda S, Tanaka K. Anticancer Res; 2013 Mar 04; 33(3):997-1001. PubMed ID: 23482772 [Abstract] [Full Text] [Related]
24. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area. Ungtrakul T, Mahidol C, Chun-On P, Laohapand C, Siripongsakun S, Worakitsitisatorn A, Vidhayakorn S, Boonchuay W, Dechma J, Sornsamdang G, Soonklang K, Sriprayoon T, Tanwandee T, Auewarakul CU. World J Gastroenterol; 2016 Sep 14; 22(34):7806-12. PubMed ID: 27678364 [Abstract] [Full Text] [Related]
28. [Clinical significance of transiently elevated serum AFP level in developing hepatocellular carcinoma in HBsAg positive-liver cirrhosis]. Lee HY, Jung JH, Kang YS, Kim YS, Moon HS, Park KO, Lee YS, Kim SM, Seo SW, Lee SW, Kim SH, Lee BS, Kim NJ. Korean J Gastroenterol; 2004 Apr 14; 43(4):252-9. PubMed ID: 15100489 [Abstract] [Full Text] [Related]
31. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study. Ji J, Wang H, Li Y, Zheng L, Yin Y, Zou Z, Zhou F, Zhou W, Shen F, Gao C. PLoS One; 2016 Apr 14; 11(4):e0153227. PubMed ID: 27070780 [Abstract] [Full Text] [Related]
32. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients. Lim TS, Kim DY, Han KH, Kim HS, Shin SH, Jung KS, Kim BK, Kim SU, Park JY, Ahn SH. Scand J Gastroenterol; 2016 Mar 14; 51(3):344-53. PubMed ID: 26340708 [Abstract] [Full Text] [Related]
33. Serum insulin-like growth factor-II and alpha-fetoprotein as tumor markers of hepatocellular carcinoma. Tsai JF, Jeng JE, Chuang LY, You HL, Ho MS, Lai CS, Wang LY, Hsieh MY, Chen SC, Chuang WL, Lin ZY, Yu ML, Dai CY. Tumour Biol; 2003 Mar 14; 24(6):291-8. PubMed ID: 15004489 [Abstract] [Full Text] [Related]
34. Combination of DKK1 and AFP improves diagnostic accuracy of hepatocellular carcinoma compared with either marker alone. Erdal H, Gül Utku Ö, Karatay E, Çelik B, Elbeg Ş, Doğan İ. Turk J Gastroenterol; 2016 Jul 14; 27(4):375-81. PubMed ID: 27458854 [Abstract] [Full Text] [Related]
40. The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma. Wang M, Devarajan K, Singal AG, Marrero JA, Dai J, Feng Z, Rinaudo JA, Srivastava S, Evans A, Hann HW, Lai Y, Yang H, Block TM, Mehta A. Cancer Prev Res (Phila); 2016 Feb 14; 9(2):172-9. PubMed ID: 26712941 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]